Stereochemical and conformational study on Fenoterol (cas 13392-18-2) by ECD spectroscopy and TD-DFT calculations

Add time:07/30/2019    Source:sciencedirect.com

Fenoterol (cas 13392-18-2) and its derivatives are selective β2-adrenergic receptor (β2-AR) agonists whose stereoselective biological activities have been extensively investigated in the past decade; a complete stereochemical characterization of fenoterol derivatives is therefore crucial for a better understanding of the effects of stereochemistry on β2-AR binding. In the present project, the relationship between chiroptical properties and absolute stereochemistry of the stereoisomers of fenoterol (1) was investigated by experimental ECD spectroscopy and time-dependent density functional theory (TD-DFT). DFT geometry optimizations were carried out at the RI-B97D/TZVP/IEFPCM(MeOH) level and subsequent TD-DFT calculations were performed using the PBE0 hybrid functional.Despite the large pool of equilibrium conformers found for the investigated compounds and the known limitations of the level of theory employed, the computational protocol was able to reproduce the experimental ECD spectra of the stereoisomers of 1. The main contribution to the overall chiroptical properties was found to arise from the absolute configuration of the chiral center in α-position to the resorcinol moiety. Based on this evidence, a thorough conformational analysis was performed on the optimized DFT conformers, which revealed the occurrence of a different equilibrium between conformational patterns for the diastereomers of fenoterol: the (R,R′)/(S,S′) enantiomeric pair showed a higher population of folded conformations than the (R,S′)/(S,R′) pair.

We also recommend Trading Suppliers and Manufacturers of Fenoterol (cas 13392-18-2). Pls Click Website Link as below: cas 13392-18-2 suppliers

Prev:In vitro transdermal permeation of Fenoterol (cas 13392-18-2) hydrobromide
Next:Anti-inflammatory activities of Fenoterol (cas 13392-18-2) through β-arrestin-2 and inhibition of AMPK and NF-κB activation in AICAR-induced THP-1 cells)